Psilocybin restores social novelty investigation in male SAPAP3 knockout mice and engages prefrontal-hippocampal circuitry

Paper. Gattuso JJ, Bezcioglu B, Hendey J et al.. Molecular Psychiatry, 17 Sep 2026.

Tags: Animal, Psilocybin, OCD.

Weekly Science Digest, 19 Sep 2026 to 25 Sep 2026, finding 3: Mechanism and acute-state work

Intranasal DMT plus harmine made EEG microstate sequences shorter and less random.

In a 25-person double-blind crossover, the DMT/harmine formulation cut microstate duration and raised occurrence and complexity versus harmine alone or placebo; Markov analysis showed transitions became less random, not more.

Weekly Science Digest, 12 Sep 2026 to 18 Sep 2026, finding 2: How much does 5-HT2A actually do?

Blocking 5-HT2A failed to abolish psilocybin's fear-extinction and BDNF effects in mice.

Pretreatment with ketanserin or the selective antagonist MDL100907 left psilocybin's facilitation of extinction, hippocampal and prefrontal BDNF, and dentate doublecortin counts largely intact. Separately, a single 1 mg/kg dose restored novel-mouse investigation in SAPAP3 knockouts seven days later — in males only.

Read the original

—
Node—
Statuslive
Throughput—